Summary Neuron specific enolase (NSE) is widely used as a neuro-endoctrine marker. However the presence of NSE in many non-neuroendocrine tissues has raised questions on the specificity of NSE. We have investigated NSE immunoreactivity (NSA-ag), y-enolase activity and total enolase activity in small cell lung cancer (SCLC) (Bepler et al., 1987; Carney et al., 1985; Gazdar et al., 1985; Bepler et al., 1989a; Broers et al., 1985; Moody et al., 1985; Broers et al., 1988 NSE is widely used as a neuroendocrine marker. NSEimmuno reactivity is not only seen in neurons, but also in neuroendocrine cells present in endocrine glands and in the diffuse neuroendocrine systems of the lung, intestine, thymus and skin. NSE has been demonstrated in tumours, thought to arise from the neuroendocrine cell system, such as SCLC, neuroblastoma, carcinoid, pancreatic islet cell tumours and medullary thyroid carcinoma (Schmechel et al., 1978; Tapia et al., 1981; Wick et al., 1983) . NSE is also present in erythrocytes, lymphocytes and platelets (Marangos et al., 1980b; Hullin et al., 1980) and in malignant lymphomas, testicular cancer, hypernephroma and non-small cell lung cancer (Takashi et al., 1989; Ariyoshi et al., 1983; Kuzmits et al., 1987; Pinto et al., 1989; Oka et al., 1989; Niehans et al. 1988) . Such observations question the correlation between NSE and the neuroendocrine cell system (Schmechel, 1985 
Since the beginning of the eighties numerous continuously growing cell-lines from Small Cell Lung Cancer (SCLC) biopsies have been established. Investigators at the National Cancer Institute (Bethesda, USA) were the first to distinguish two types of cell-lines i.e. variant and classic cell-lines, characterised by the absence or presence respectively of the enzyme L-dopadecarboxylase. In comparison with classic cell lines variant cell lines were shown to have a higher growth rate, a higher cloning efficiency, a larger cell volume, a lower content of Neuron-Specific Enolase (NSE), amplification of c-myc, absence of gastrin releasing peptide (GRP) and neurotensin, and a decreased sensitivity to radiotherapy and chemotherapy (Bepler et al., 1987; Carney et al., 1985; Gazdar et al., 1985; Bepler et al., 1989a; Broers et al., 1985; Moody et al., 1985; Broers et al., 1988) . Recently Bepler et al. (1989b) added a third class, so-called transitional cells, based on the presence of p64 c-myc in some of the classic cell lines. The addition of a third class of cell lines, is substantiated by intermediate levels of neuroendocrine markers, growth rate and cloning efficiency.
NSE is widely used as a neuroendocrine marker. NSEimmuno reactivity is not only seen in neurons, but also in neuroendocrine cells present in endocrine glands and in the diffuse neuroendocrine systems of the lung, intestine, thymus and skin. NSE has been demonstrated in tumours, thought to arise from the neuroendocrine cell system, such as SCLC, neuroblastoma, carcinoid, pancreatic islet cell tumours and medullary thyroid carcinoma (Schmechel et al., 1978; Tapia et al., 1981; Wick et al., 1983) . NSE is also present in erythrocytes, lymphocytes and platelets (Marangos et al., 1980b; Hullin et al., 1980) and in malignant lymphomas, testicular cancer, hypernephroma and non-small cell lung cancer (Takashi et al., 1989; Ariyoshi et al., 1983; Kuzmits et al., 1987; Pinto et al., 1989; Oka et al., 1989; Niehans et al. 1988) . Such observations question the correlation between NSE and the neuroendocrine cell system (Schmechel, 1985 (1992) , 66, [1065] [1066] [1067] [1068] [1069] immunoreactivity, enolase enzyme activity, enolase isoenzyme composition and protein content.
Neuron specific enolase immunoreactivity NSE-immunoreactivity (NSE-ag) was determined with the Pharmacia NSE-RIA, as previously described (Cooper et al., 1985) .
Enolase enzyme activity Enolase (2-phospho-D-glycerate hydrolase: EC4.2. 1.11) activity was measured in 100 mM Tris/HCI buffer pH 8.0, containing 100 mM MgCl2, 100 mM KCI, 0.5 mM EDTA, 1.5 mM ADP (Boehringer), 0.2 mM NADH (Sigma), 0.5 U ml-' pyruvate kinase (Boehinger) and 1.0 U ml-' lactate dehydrogenase (Boehringer). The reaction mixture was preincubated for 10 min at 30°C. The reaction was started with the substrate glycero-2-phosphate 1 mM (Boehringer) and assayed kinetically in a Philips PU 8720 spectophotometer at 340 nm and 30°C (Oskam et al., 1985) . The supernatant was chosen so as to contain an enolase enzyme activity between 50 and 500 U 1' within these values a linear correlation existed between enolase enzyme activity and protein content of the different cell lines.
Enolase isoenzymes Enolase isoenzymes were separated on cellulose acetate gel (Cellogel) in 20 mM sodium-phosphate buffer pH 7.0 and enolase activity as determined as described previously (Oskram et al., 1985) .
L-dopa decarboxylase L-dopa decarboxylase (aromatic L-amino acid decarboxylase; ALAAD) was measured as described previously (Boomsma et al., 1986 ) and expressed as mU 10-6 cells. For measuring ALAAD activity a frozen cell pellet, containing a known number of cells, was dissolved and further diluted when necessary in bidistilled water containing 40 g I`of bovine serum albumin and 10gl-l of glutathione.
Purification of NSE and production of antiserum Human NSE was purified from postmortem human brain cortex and the antiserum was produced in rabbits (Haglid et al., 1973) . This antiserum was extensively absorbed with human non-neuronal enolase until the resulting rabbit anti-NSE did not show any crossreactivity with a-enolase in an ELISA (Aurell et al., 1989) . differences between the means of two groups was tested by the Student's t-test. When a P-value was less than 0.05 the difference was regarded significant. Doubling time (Td) and NSE-immunoreactivity (NSE-ag) During strictly controlled exponential growth the doublingtime, NSE-ag, enolase and ALAAD-enzyme activity were measured in 23 different passages of 11 different cell lines 2, 4, (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) 8, 11, 14, 16, 19, 28 and 34) . The first three cell lines (GLC-1, 2 and 4) did not contain ALAAD activity and were therefore called variant, the remaining cell lines were classified as classic. As shown in Figure 1 the NSE-ag/Td ratio distinguished two groups of cell lines: at the left GLC-1, 2, 4, 1-13, 8, 11, 16, 19 and earlier passages of GLC 14 and 28; at the right GLC-34 and later passages of GLC-14 and 28. Each group showed a highly significant correlation between NSE-ag content and Td. (Correlation coefficients were 0.95 and 0.99 of the left and right group respectively, the P-values <0.0001 for both). The mean NSEag level was significantly different between both groups (606 ± 250 vs 1852 ± 293 ng mg-' protein, P<0.0001). More- over the NSE-ag levels of both groups did not show an overlap. Although the mean Td of the left group was significantly different from the Td of the right group (36.9 ± 10.4 h 53 ± 17 h respectively, P = 0.01), there was an evident overlap of Td's between both groups. The mean ALAAD-activity of only the classic cell lines in both groups was similar (0.805 ± 0.574 and 0.818 ± 0.606 mU 10-6 cells, P = 0.9) and the mean enolase-activity of the left and the right group was 0.856 ± 0.213 and 0.624 ± 0.117 U mg-' protein respectively (P = 0.02). The cell lines, belonging to the group at the left in Figure 1 , were called type I and the cell lines on the right type II.
NSE-immunoreactivity (NSE-ag), total enolase-and y-enolase enzyme activity As shown in Figure 2 the ratio between NSE-ag content and total enolase activity, measured in the same cell lines of the paragraph above, also distinguished the same two types of cell lines with the exception of GLC 1-13 and 16 (open squares). The mean ratio for type I cell lines was 635 ± 144 ng U ' and for the right group 2994 ± 350 ng U-' (P<0.0001). These data indicated the existence of an abrupt increase of NSE-ag without enzyme activity between the two types of cell lines. The ratios for the two exceptional cell lines were 1193 and 1294 respectively. Both cell lines had NSE-ag contents in earlier passages consistent with type II cell lines. Six and nine passages later the Td had decreased from 56 to 35 h and from 60 to 39 h respectively at which time the ratio Immunoblotting with anti-NSE Samples of the various SCLC-cell lines were sonicated (Branson, Sonifier, cell disruptor B15) in 1% SDS at 90°C until a clear solution was obtained, usually no longer than 60 sec. (Wang et al., 1990) . Samples of sonicated SCLC-cell lines were run in SDS gel electrophoresis, using a 5-10% linear polyacrylamide slab gel. The proteins were transferred to a 0.45 ItM nitrocellulose membrance according to Towbin et al. (1979) except that 0.1% SDS was added to the transfer buffer. The electrophoretic blots were detected using rabbit anti-NSE serum (absorbed xix) (diluted 1:500 in TRISbuffered saline) as the first antibody and peroxidaseconjugated goat anti-rabbit IgG (diluted 1:200) as the second antibody Diaminobenzidine (0.5 mg ml-' in TBS) and H202 (0.03%) were used as the enzyme substrate for the colour reaction.
Statistical methods
The date are presented as the mean ± the standard deviation of the mean. Correlation coefficients were estimated by using a simple linear regression analysis. 8, 11, 14, 19, 28 and 34 the percentage of enzymatically active oaa, cry, 'y chains was measured. The percentage of enzymatically active y-chains was calculated by adding half of the percentage of ay-isoenzymes and two times the percentage of yy-isoenzymes. NSE-ag was determined in only 13 of these cell lines. The ratio between y-enolase activity and NSE-ag level again distinguished two types of cell lines, which were further characterised by a significant difference of the mean enolase activity, mean NSE-ag content and mean Td and an abrupt increase of NSe-ag without enzyme activity between both types (data not shown). In addition the mean y-enolase activity of the two groups was 33.5 ± 29 mU mg-' protein and 150 ± 45 mU mg' protein (P<0.0001) respectively and the mean percentage of enzymatically active 'y-chains 4.2 ± 2.3% and 25.9 ± 3.6% (P<0.0001) respectively. As shown in Figure 3 a significant correlation was found between the log y-enolase activity and log NSE-ag content in both types (y = 1.39 x -1.1 1, r=0.94, P=0.001 for type I; y= 1.28 x-1.83, r=0.97, P= 0.005 for type II). Interestingly the slope of both regression lines was almost identical. These data indicate that the logarithmic increase of y-enolase activity is significantly correlated with the logarithmic increase of NSE-ag content in an almost identical way in both types of cell lines but at a different NSE-ag level. The NSE-ag level shows an abrupt increase without enzyme activity between both types.
The percentage of enzymatically active 'y-chains in type I cell lines was significantly correlated with the y-enolase activity. However no such correlation was observed in type II cell lines (Figure 4) .
Immunoblotting
An immunoblotting assay with polyclonal rabbit antibodies against human --enolase was performed on extracts of a variant (GLC-2), a transitional (GLC-8) and a classic (GLC-34) cell line. Purified human yy-enolase and human brain cortex grey matter were used as references. All cell lines
Discussion
The relevance of the distinction between classic, transitional and variant cells in vitro has not been demonstrated in vivo. This is mainly due to the heterogeneity of the tumour and difficulty to obtain representative and sufficient tumour material from patients. Therefore our attention focused on tumour markers as a possible source of information about the composition of SCLC-tumours in vivo. Neuron-specific enolase (NSE) is one of the most widely used tumour markers in SCLC. It has been shown to be a clinically reliable tool to monitor the course of the disease (Cooper et al., 1985; Splinter et al., 1987a; Splinter et al., 1989) , the doubling-time of NSE at relapse was highly significantly correlated with survival from time of relapse (Splinter et al., 1987b ) and pretreatment-values were shown to have prognostic value by some (J0rgenson et al., 1988) , but not by others (Van der Gaast et al., 1991) . Moreover NSE is a good marker for neuronal differentiation and maturation (Schmechel et al., 1980) . However the presence of NSE in many non-neuronal and non-neuroendocrine tissues together with a lack of understanding how a relatively unimportant Log NSE -ag (ng mg-' protein) Figure 3 Correlation between intracellular log y-enolase activity (mU mg-I protein) and log NSE (ng mg'l protein). l ( = variant) plus * ( = classic) are called type I, A ( = classic) is called type II. glycolytic enzyme might play such a distinct role in differentiation raised the question whether NSE was not neuronspecific but nonspecific (Schmechel, 1985) . Therefore we started to investigate the relationship between NSE and biological behaviour in SCLC-cell lines. Two types of cell lines could be distinguished by significant differences of NSEag content, total enolase-and y-enolase enzyme activity, Td and an abrupt appearance or increase of NSE-ag without enzyme activity, which was reflected in significantly different NSE-ag/enolase ratios and NSE-ag/y-enolase ratios. In both types the NSE-ag content and y-enolase activity (data not shown) were linearly correlated with the Td, albeit at two different levels. It is therefore concluded that y-enolase activity seems to be associated with the regulation of growth rate. In addition in type II cell lines, but not in type I cell lines, a dissociation was observed between the percentage of enzymatically active y-chains and y-enolase activity. This may indicate that in type II cell lines either the production of enzymatically active y-chains is dissociated from the production of a-chains or active y-chains are inactivated by a mechanism, which acts independent of the regulation of production. Recently it was shown that V-src could induce phosphorylation of glycolytic enzymes, such as enolase and especially -y-enolase (Cooper et al., 1983) . Phosphorylation of y-enolase led to partly inactivation of the enzyme, accompanied by an increase of the total amount of the enzyme (Eigenbrodt et al., 1983) . Moreover c-src expression in neuroblastoma-and SCLC-cell lines correlated with neuroendocrine differentiation (Mellstrom et al., 1987) and c-src is connected to neurogenesis and neuronal differentiation (Brickel et al., 1991) , as is the switch from a to y-enolase (Schmechel et al., 1980) . In this connection it is very interesting that Wevers et al. (1988) found in cerebrospinal fluid but not in serum from healthy individuals that 50% of NSE-ag had no enzyme activity. These data suggest that NSE-ag without enzyme activity may arise from inactivation of ychains and may be correlated with neuronal or neuroendocrine differentiation. However, it is also possible that inactivation of y-enolase by phosphorylation merely reflects protein kinase activity, leading to different changes in different cell types. With polyclonal rabbit antibodies against yenolase we could not demonstrate the presence of a compound which migrated differently from y-enolase. Whatever the explanation, characterisation of NSE-ag without enzyme activity, investigation of the regulation of its production and of the production of active 'y-enolase may produce more information about the growth rate and differentiation of SCLC-cell lines. The data presented in this paper support the distinction of two new classes of SCLC-cell lines, type I and II, with different biological characteristics. Possibly the classic cell lines, belonging to type I, are similar to the transitional cell lines, characterised by the presence of p64 c-myc (Bepler et al., 1989b) . Whether such a distinction in vitro has any relevance in vivo should be and possibly can be investigated by measuring the ratio between NSE-ag and y-enolase activity in serum samples from patients with SCLC. A comparison of enzyme activity and immunoreactivity by Sorensen et al. (1988) in serum samples from five SCLC-patients showed that at least in some samples the amount of NSE-ag and y-enolase activity were significantly different.
Finally, the demonstration that 'neuron-specific enolase' measured with an antibody, can be the enzyme NSE or an enzymatically inactive compound emphasises that further investigations about neuron-specificity of NSE needed. It may be that NSE immunoreactivity in neuroendocrine cells is different from the one in non-neuroendocrine cells.
